Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors
Open Access
- 12 January 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 158 (1), 26-32
- https://doi.org/10.1001/archinte.158.1.26
Abstract
ANGIOTENSIN-converting enzyme (ACE) inhibitors are widely used in the treatment of several common clinical conditions. It has been estimated that ACE inhibitors accounted for 24% of the antihypertensive agents prescribed in 1993.1 In other conditions, such as congestive heart failure2 and diabetic nephropathy,3 they have been shown to improve important clinical outcomes.Keywords
This publication has 30 references indexed in Scilit:
- Long-Term Effects of the Angiotensin Converting Enzyme Inhibitor Captopril on Metabolic Control in Non – Insulin-Dependent Diabetes MellitusAmerican Journal of Hypertension, 1993
- Safety of long-term use of lisinopril for congestive heart failureThe American Journal of Cardiology, 1992
- Effects of antihypertensive agents on coronary artery disease risk factorsThe American Journal of Cardiology, 1992
- Comparative Effects of Long-Term Therapy with Captopril and Ibopamine in Chronic Congestive Heart Failure in Old PatientsJMIR AI, 1991
- Spironolactone and altizide versus converting enzyme inhibitor (enalapril)The American Journal of Cardiology, 1990
- The Safety and Tolerability of QuinaprilJournal of Cardiovascular Pharmacology, 1990
- The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black PopulationThe Journal of Clinical Pharmacology, 1989
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.BMJ, 1988
- Once Daily Dosing of Enalapril in Congestive Heart FailureActa Medica Scandinavica, 1988
- Captopril in essential hypertension.British Journal of Clinical Pharmacology, 1982